Activated Charcoal Apis Mellifera Bos Taurus Pitui

證據等級: L5 預測適應症: 0

目錄

  1. Activated Charcoal Apis Mellifera Bos Taurus Pitui
  2. Homeopathic Multi-Ingredient Complex (Activated Charcoal / Potassium Iodide / Spongia et al.): No Repurposing Prediction Available
    1. One-Sentence Summary
    2. Quick Overview
    3. Why No Prediction Was Generated
    4. US Market Information
    5. Safety Considerations
    6. Conclusion and Next Steps
    7. Disclaimer

## 藥師評估報告

Homeopathic Multi-Ingredient Complex (Activated Charcoal / Potassium Iodide / Spongia et al.): No Repurposing Prediction Available


One-Sentence Summary

This submission contains a complex homeopathic multi-ingredient product composed of nine distinct substances — including Activated Charcoal, Potassium Iodide, Lycopus Virginicus, and Spongia Officinalis — with no registered US market authorization and no recognized original indication on record. The TxGNN model was unable to generate any repurposing predictions for this candidate, as no DrugBank identifier could be assigned to this multi-ingredient mixture. As a result, no evidence from clinical trials or literature is linked to this candidate under the current pipeline.


Quick Overview

Item Content
Original Indication Not available (no US market authorization on record)
Predicted New Indication None — TxGNN returned no predictions
TxGNN Prediction Score N/A
Evidence Level L5 (model prediction only — in this case, none generated)
US Market Status ✗ Not Marketed
Number of NDAs 0
Recommended Decision Hold

Why No Prediction Was Generated

This candidate is a complex multi-ingredient homeopathic formulation containing nine substances:

  1. Activated Charcoal — adsorbent, used clinically for acute poisoning
  2. Apis Mellifera — whole bee, used homeopathically
  3. Bos Taurus Pituitary Gland, Posterior — bovine posterior pituitary gland, homeopathic use
  4. Conium Maculatum Flowering Top — poison hemlock, used homeopathically
  5. Lachesis Muta Venom — bushmaster snake venom, used homeopathically
  6. Lycopus Virginicus Whole — bugleweed, traditionally used for hyperthyroidism
  7. Phosphorus — used homeopathically
  8. Potassium Iodide — clinically used for thyroid conditions and radiation protection
  9. Spongia Officinalis Skeleton, Roasted — roasted sea sponge, classic homeopathic agent for thyroid/goiter

The TxGNN knowledge graph operates on a per-compound DrugBank node basis. Because this mixture has no assigned DrugBank ID — and cannot be resolved to a single molecular entity — the model has no entry point in the knowledge graph, making drug–disease link prediction impossible under the current architecture.

The combination of Lycopus Virginicus, Potassium Iodide, and roasted Spongia Officinalis is suggestive of a thyroid-targeted homeopathic formula (these three are classically combined in homeopathic practice for hyperthyroid symptoms and goiter). However, this interpretation is based on traditional use patterns only and cannot be confirmed without MOA data or regulatory documentation.


US Market Information

No US market authorizations (NDAs or ANDAs) were found for this product or any of its formulation combinations under the TFDA/FDA query conducted on 2026-03-24.


Safety Considerations

No safety data — including warnings, contraindications, or drug–drug interactions — is currently available for this multi-ingredient combination as a unified product.

Please refer to the individual ingredient package inserts and relevant pharmacopoeia monographs for component-level safety information. Note in particular that Conium Maculatum (poison hemlock) and Lachesis Muta Venom carry significant toxicological profiles at non-homeopathic concentrations, and Potassium Iodide has known interactions with thyroid medications and lithium.


Conclusion and Next Steps

Decision: Hold

Rationale: This candidate cannot be evaluated under the current TxGNN repurposing pipeline because it is a heterogeneous multi-ingredient homeopathic mixture with no DrugBank ID, no US regulatory authorization, no original indication on record, and no TxGNN prediction output. There is insufficient structured data to proceed to any repurposing assessment stage.

To proceed, the following is needed:

  • Clarify product identity: Determine whether this is an OTC homeopathic product (e.g., an HPUS-listed combination remedy). If so, retrieve the HPUS monograph or any FDA OTC monograph coverage.
  • Assign individual DrugBank IDs: Each active ingredient should be queried separately. At minimum, Activated Charcoal (DB09160), Potassium Iodide (DB00345), and Lycopus Virginicus may have individual nodes in the knowledge graph.
  • Re-run TxGNN per-ingredient: Break the formulation into individual pharmacologically active components and run separate repurposing predictions for each, then aggregate results.
  • Obtain MOA documentation: Retrieve mechanistic data for each active ingredient from DrugBank API.
  • Determine intended indication: Consult product labeling or the submitting sponsor for the claimed therapeutic use.
  • Safety profile per component: Retrieve individual DDI and contraindication data for Potassium Iodide, Activated Charcoal, Lycopus Virginicus, and Conium Maculatum at minimum.

    Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.



Copyright © 2026 UsTxGNN Project. For research purposes only.

This site uses Just the Docs, a documentation theme for Jekyll.